{"product_id":"tirzepatide","title":"Tirzepatide","description":"\u003cp\u003eTirzepatide (also known as texipatide) is the world's first glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) dual receptor agonist developed by Eli Lilly and Company. It is primarily used for the treatment of type 2 diabetes, chronic weight management in adults, and as adjunctive therapy for moderate to severe obstructive sleep apnea.\u003c\/p\u003e","brand":"Peptides","offers":[{"title":"Default Title","offer_id":51991544889639,"sku":null,"price":49.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1004\/1249\/0023\/files\/photo_2026-09-08_02-43-36.jpg?v=1788806632","url":"https:\/\/novo-medical.com\/products\/tirzepatide","provider":"Peptides","version":"1.0","type":"link"}